Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totaling 3,900 shares, adeclineof43.5% from the July 15th total of 6,900 shares. Currently,0.0% of the company's stock are short sold. Based on an average daily volume of 189,700 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 189,700 shares, the short-interest ratio is presently 0.0 days. Currently,0.0% of the company's stock are short sold.
Ascend Wellness Price Performance
Shares of AAWH stock traded up $0.02 during trading hours on Monday, reaching $0.67. The company's stock had a trading volume of 594,821 shares, compared to its average volume of 139,724. The firm's 50 day simple moving average is $0.39 and its 200-day simple moving average is $0.36. The company has a market capitalization of $136.81 million, a price-to-earnings ratio of -1.63 and a beta of 1.04. Ascend Wellness has a fifty-two week low of $0.26 and a fifty-two week high of $1.23. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 2.61.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Ascend Wellness to a "strong sell" rating in a research note on Tuesday, August 12th.
View Our Latest Analysis on AAWH
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.